ADAMERCK
Adamerck engages in the research and development of innovative drugs with independent intellectual property rights. The company has carried out more than 10 innovative drug research and development with independent intellectual property rights, all of which are urgently needed clinically and developed globally, with broad market prospects. These drugs are involved in anesthesia, cardiovascular and cerebrovascular, tumor, and other application fields.
ADAMERCK
Industry:
Health Care Medical Pharmaceutical
Founded:
2000-10-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.adamerck.net
Status:
Active
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Mobile Non Scaleable Content Apache Pound Sterling Japanese Yen Laravel Alibaba CNZZ
Similar Organizations
AscorBio Lab
AscorBio Lab engages in the research and development, product planning, and manufacturing operations for vitamin C derivatives.
Betta Pharmaceuticals
Betta Pharmaceuticals is a company that develops and distributes pharmaceutical drugs for prospective patients.
Eisai Korea
Eisai Korea engages in research and development of prescription drugs to generic drugs.
Huvet Bio
Huvet Bio is engaged in the research and development of bio pharmaceuticals.
Rhino Medical
Rhino Medical develops an advanced technologies with independent intellectual property rights.
Tyercan
Tyercan focuses on the research and development of innovative targeted anti-cancer and immunosuppressive drugs.
VesiCURE Therapeutics
VesiCURE Therapeutics engages in the research and development of exosome innovative drugs.
Weihe Pharma
Weihe Pharma engages in the research and development of natural herbal medicines.
Official Site Inspections
http://www.adamerck.net
- Host name: 121.41.81.221
- IP address: 121.41.81.221
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Adamerck"
Adamerck - Crunchbase Company Profile & Funding
Adamerck engages in the research and development of innovative drugs with independent intellectual property rights. The company has carried out more than 10 innovative drug …See details»
杭州奥默医药股份有限公司
奥默医药在新药研发领域潜心耕耘20年，始终秉承“明日之药，康泽生命”的企业宗旨，以药物的创新设计和新药的产品化研发为核心竞争力，凭借海归团队的专业技术和管理优势，整合各方资 …See details»
Adamerck Company Profile 2024: Valuation, Funding & Investors
Adamerck General Information Description. Operator of a high-tech pharmaceutical enterprise focusing on the research and development of innovative drugs. The company is committed to …See details»
Aomo Pharma Inc.
Aomo Pharma Inc. (the US branch of Adamerck) is a biotechnology company cofound by Ph.D. Youmao Qi and Qing Jie in 2000. Since establishment, we are driven by a culture of innovation and commit to creating "better drugs for …See details»
了解我们|杭州奥默医药股份有限公司 - adamerck.net
About Adamerck; R&D Team; Company culture; Honor; 公司核心团队主要由海外高层次人才和国内技术专家组成。2018年中国科学院院士、国家重大科技专项“重大新药创制”技术副总师、国 …See details»
Hangzhou Adamerck Pharmlabs Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Hangzhou Adamerck Pharmlabs Inc. of Hangzhou, Zhejiang. Get the latest business insights from Dun & …See details»
Hangzhou Adamerck | VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Hangzhou Adamerck Pharmlabs Inc. Asset Profile | Preqin
Based in Zhejiang, China and founded in 2000, Hangzhou Adamerck Pharmlabs Inc. is a pharmaceutical enterprise, being dedicated to the research and development of innovative …See details»
Adamerck - Crunchbase
Adamerck engages in the research and development of innovative drugs with independent intellectual property rights.See details»
Adamerck - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 Adamerck engages in the research and development of innovative drugs with independent intellectual property rights.See details»
Aomo Pharma Inc.
ACADEMICIAN WORKSTATION LEADING SCIENTISTS CORE TEAM COLLABORATING SCIENTISTS AND ORGANIZATION OUR FOCUS PIPELINE IN-DEPTH LOOK SCIENTIFIC PUBLICATION PRESS RELEASE MEDIA …See details»
Adamerck - Company Information, Competitors, News & FAQs
Find useful insights on Adamerck's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Adamerck.See details»
Aom-0207 - Drug Targets, Indications, Patents - Synapse
Aom-0207, Initially developed by Hangzhou Adamerck Pharmlabs, Inc., Now, its global highest R&D status is Discovery, Therapeutic Areas: Digestive System Disorders, Active Indication: …See details»
Patents Assigned to HANGZHOU ADAMERCK PHARMLABS INC.
Dec 28, 2018 Assignee: Hangzhou Adamerck Pharmlabs, Inc. Inventor: Youmao Qi 6-deoxy-6-thioether-amino acid cyclodextrin derivative and preparation method thereof. Patent number: …See details»
Aom-0187 - Drug Targets, Indications, Patents - Synapse - Patsnap
Aom-0187, Initially developed by Hangzhou Adamerck Pharmlabs, Inc., Now, its global highest R&D status is Discovery, Therapeutic Areas: Eye Diseases, Active Indication: Dry Eye …See details»
Aom-0785 - Drug Targets, Indications, Patents - Synapse - Patsnap
Aom-0785, Initially developed by Hangzhou Adamerck Pharmlabs, Inc., Now, its global highest R&D status is Pending, Therapeutic Areas: Infectious Diseases. ... Originator Organization. …See details»
Aom 0187 - AdisInsight
Nov 4, 2022 20 Oct 2022 Hangzhou Adamerck has patent protection and patents pending (Hangzhou Adamerck pipeline, October 2022) 20 Oct 2022 Early research in Dry eyes in …See details»
AdamErck - GitHub
GitHub is where AdamErck builds software. GitHub is where AdamErck builds software. Skip to content. Toggle navigation. Sign in AdamErck. Product Actions. Automate any workflow …See details»
Members · People · AdamErck - GitHub
GitHub is where AdamErck builds software. Skip to content. Navigation Menu Toggle navigation. Sign in Product Actions. Automate any workflow Packages. Host and manage packages …See details»
Aom-0304 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 1, 2023 Aom-0304, Initially developed by Hangzhou Adamerck Pharmlabs, Inc.. Aom-0304, Initially developed by Hangzhou Adamerck Pharmlabs, Inc.. Biomedical products. Data. …See details»